Sebastiano Toniolo
Overview
Explore the profile of Sebastiano Toniolo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
197
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zuin M, Tadiello E, Toniolo S, Loddo I, Tenaglia R, Bilato C
G Ital Cardiol (Rome)
. 2023 Apr;
24(5):373-379.
PMID: 37102350
Background: Update data regarding acute myocardial infarction (AMI)-related mortality in Italy remain scant. We assessed AMI-related mortality and time trends in Italy from 2007 to 2017 by using the Eurostat...
2.
Bertelli M, Toniolo S, Ziacchi M, Gasperetti A, Schiavone M, Arosio R, et al.
J Clin Med
. 2023 Mar;
12(6).
PMID: 36983448
The authors wish to make the following corrections to this paper [...].
3.
Bertelli M, Toniolo S, Ziacchi M, Gasperetti A, Schiavone M, Arosio R, et al.
J Clin Med
. 2022 Oct;
11(20).
PMID: 36294401
(1) Background: Leadless (LL) stimulation is perceived to lower surgical, vascular, and lead-related complications compared to transvenous (TV) pacemakers, yet controlled studies are lacking and real-life experience is non-conclusive. (2)...
4.
Piemontese G, Toniolo S, Biffi M, Capobianco C, Bartoli L, Sorrentino S, et al.
Rev Cardiovasc Med
. 2022 Mar;
23(3):107.
PMID: 35345274
Cardiac simulation has moved from early life-saving pacemakers meant only to prevent asystole to current devices capable of physiologic stimulation for the treatment of heart rhythm and heart failure, that...
5.
Paolisso P, Foa A, Bergamaschi L, Angeli F, Fabrizio M, Donati F, et al.
Cardiovasc Diabetol
. 2021 Sep;
20(1):192.
PMID: 34560876
Background: The prognostic role of hyperglycemia in patients with myocardial infarction and obstructive coronary arteries (MIOCA) is acknowledged, while data on non-obstructive coronary arteries (MINOCA) are still lacking. Recently, we...
6.
Paolisso P, Foa A, Bergamaschi L, Donati F, Fabrizio M, Chiti C, et al.
Cardiovasc Diabetol
. 2021 Feb;
20(1):33.
PMID: 33530978
Background: Hyperglycemia has been associated with increased inflammatory indexes and larger infarct sizes in patients with obstructive acute myocardial infarction (obs-AMI). In contrast, no studies have explored these correlations in...
7.
Bergamaschi L, DAngelo E, Paolisso P, Toniolo S, Fabrizio M, Angeli F, et al.
Ann Noninvasive Electrocardiol
. 2021 Jan;
26(3):e12815.
PMID: 33512742
Background: There is growing evidence of cardiac injury in COVID-19. Our purpose was to assess the prognostic value of serial electrocardiograms in COVID-19 patients. Methods: We evaluated 269 consecutive patients...
8.
Biffi M, Capobianco C, Spadotto A, Bartoli L, Sorrentino S, Minguzzi A, et al.
Expert Rev Med Devices
. 2020 Dec;
18(2):161-177.
PMID: 33336616
: Cardiac stimulation evolved from life-saving devices to prevent asystole to the treatment of heart rhythm disorders and heart failure, capable of remote patient and disease-progression monitoring. Cardiac stimulation nowadays...
9.
DAngelo E, Paolisso P, Vitale G, Foa A, Bergamaschi L, Magnani I, et al.
JACC Cardiovasc Imaging
. 2020 Jun;
13(11):2400-2411.
PMID: 32563654
Objectives: This study sought to assess the diagnostic accuracy of cardiac computed tomography (CT) and F-fluorodeoxyglucose (F-FDG) with positron emission tomography/computed tomography (PET/CT) in defining the nature of cardiac masses....
10.
Paolisso P, Bergamaschi L, Saturi G, DAngelo E, Magnani I, Toniolo S, et al.
Front Pharmacol
. 2020 Feb;
10:1606.
PMID: 32082147
Background: Myocardial infarction with non-obstructive coronary arteries (MINOCA) is a heterogeneous entity with relevant long-term major cardiovascular events. Several trials have demonstrated that dual antiplatelet therapy (DAPT), β-blocker, renin-angiotensin-aldosterone system...